Browse > Article

Current Status and Vaccine Indication for Hepatitis A Virus Infection in Korea  

Jeong, Sook-Hyang (Division of Gastroenterology, Department of Internal Medicine, Seoul National University Bundang Hospital)
Publication Information
The Korean Journal of Gastroenterology / v.51, no.6, 2008 , pp. 331-337 More about this Journal
Abstract
One of the major cause of recent acute viral hepatitis in Korean adults is hepatitis A virus (HAV) infection. Most of hepatitis A cases are young adults in their twenties or thirties, and the severity of the disease is related to the age of patients. The seroprevalence of HAV among the adolescents and young adults in their teens and twenties is about 10%, which suggests that a growing number of young adults are susceptible to HAV infection. Development of more adult cases with severe presentation is expected in the near future, and some preliminary data suggest the incidence rate of hepatitis A in Korea might be higher than 20/100,000 population. This clinical features and the epidemiological shift of HAV urge to promote childhood vaccination and consider catch-up vaccination for adolescents and young adults. More extensive evaluation on the nationwide epidemiology of HAV infection, cost-benefit analysis of HAV vaccination, and setting-up of guidelines for HAV vaccination are urgently warranted. (Korean J Gastroenterol 2008;51:331-337)
Keywords
Hepatitis A virus; Acute hepatitis; Human; Vaccine; Korea
Citations & Related Records
Times Cited By KSCI : 13  (Citation Analysis)
Times Cited By SCOPUS : 8
연도 인용수 순위
1 Kang HM, Jeong SH, Kim JW, et al. Recent etiology and clinical features of acute viral hepatitis in a single center of Korea. Korean J Hepatol 2007;13:495-502.   DOI   ScienceOn
2 Jeong SH, Hwang SG, Park SJ, Kang SK, Jee Y. Current status of acute viral hepatitis in Korea; epidemiology, clinical, virological characteristics, and the effects of antiviral treatment in severe acute hepatitis B and C - intrim report. Korean J Hepatol 2007;13:S101-S107.
3 Kwon YO, Choi IJ, Jung JW, Park JH. An epidemiologic study on the seropositive rate of hepatitis A virus among a selected group of children and adults in Busan. Korean J Pediatr 2007;50:262-267.   DOI   ScienceOn
4 Lee HS, Byun JH, Kim CY. Etiology and outcome of acute viral hepatitis in Korean adults. J Korean Med Sci 1990;5: 149-154.   DOI
5 Song HJ, Kim TH, Song JH, et al. Emerging need for vaccination against hepatitis A virus in patients with chronic liver disease in Korea. J Korean Med Sci 2007;22:218-222.   DOI   ScienceOn
6 Byun KS, Kim JH, Song KJ, et al. Molecular epidemiology of hepatitis A virus in Korea. J Gastroenterol Hepatol 2001; 16:519-524.   DOI   ScienceOn
7 Yoo HJ, Yoon BC, Han BH, et al. The clinical feature of acute hepatitis A and IgG anti-HAV seroprevalence of the Busan: Single center experience. Korean J Hepatol 2007; 13:S173.
8 Park JY, Lee JB, Jeong SY, et al. Molecular characterization of an acute hepatitis A outbreak among healthcare workers at a Korean hospital. J Hosp Infect 2007;67:175-181.   DOI   ScienceOn
9 Song YB, Lee JH, Choi MS, et al. The age-specific seroprevalence of hepatitis A virus in Korea. Korean J Hepatol 2007;13:27-33.
10 Kim JH, Kang JH, Lee SY, et al. A study for seroprevalence of antibody to hepatitis A in Korea. Korean J Hepatol 2007; 13:S27.
11 Victor JC, Monto AS, Surdina TY, et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 2007;357:1685-1694.   DOI   ScienceOn
12 Eun JR, Lee HJ, Kim TN, Jang BI, Moon HJ. Clinical characteristics of adult patients with acute hepatitis A. Yeungnam Univ J Med 2007;24:170-178.   DOI
13 Kang CI, Choi CM, Park TS, Lee DJ, Oh MD, Choe KW. Incidence and seroprevalence of hepatitis A virus infection among young Korean soldiers. J Korean Med Sci 2007;22: 546-548.   DOI   ScienceOn
14 Jung PJ, Kim DH, Joo IG, et al. Clinical characteristics of sporadic hepatitis A in Gwangju-Jeonnam province. Korean J Hepatol 2005;11:S65.
15 Kim DY, Ahn SH, Lee HW, et al. Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea. Eur J Gastroenterol Hepatol 2007;19:923-926.   DOI
16 Kim HS, Kim HS, Lee JY, et al. Initial thrombocytopenia as a simple, valuable predictor for clinical manifestation in acute hepatitis A. Scand J Gastroenterol 2008;43:81-888.   DOI   ScienceOn
17 Kim TY, Sohn JH, Ahn SB, et al. Comparison of recent IgG anti-HCV prevalence between two hospitals in Seoul and Gyeonggi area. Korean J Hepatol 2007;13:363-369.   DOI   ScienceOn
18 Song KS, Kim JH, Kim YS, et al. Investigation about atypical clinical courses in patients with acute viral hepatitis A. Korean J Hepatol 2006;12:S80.
19 Hong WS, Kim CY. Seroepidemiology of type A and type B hepatitis in Seoul area. Korean J Intern Med 1982;25:19-26.
20 Lee TH, Kim SM, Lee GS, et al. Clinical features of acute hepatitis A in the western part of Daejeon and Chungnam province: Single center experience. Korean J Gastroenterol 2006;47:136-143.
21 Lee JM, Park HK, Choi KY, et al. Incidence and seroprevalence of hepatitis A virus among Korean auxiliary police officers. Infect Chemother 2007;39:292-295.
22 Bell BP. Prevention of hepatitis A virus, chapter 9. In: Thomas HC, Lemon S, Zuckerman AJ, ed. Viral hepatitis. 3rd ed. Oxford: Blackwell Publishing, 2005:126-145.
23 Jung CH, Lim YS, Kim KM, et al. Clinical outcome of 5 cases of fulminant hepatic failure caused by HAV. Korean J Hepatol 2006;12:S200.
24 Lee DH, Cho YA, Park Y, et al. Hepatitis A in Korea: epidemiological shift and call for vaccine strategy. Intervirology 2008;51:70-74.
25 Orr N, Klement E, Gillis D, et al. Long-term immunity in young adults after a single dose of inactivated hepatitis A vaccines. Vaccine 2006;24:4328-4332.   DOI   ScienceOn
26 Rein DB, Hicks KA, Wirth KE, et al. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Pediatrics 2007;119:12-21.
27 Jee YM, Go U, Cheon D, et al. Detection of hepatitis A virus from clotting factors implicated as a source of HAV infection among haemophilia patients in Korea. Epidemiol Infect 2006;134:87-93.   DOI   ScienceOn
28 Almasio PL, Amoroso P. HAV infection in chronic liver disease: a rationale for vaccination. Vaccine 2003;21:2238-2241.   DOI   ScienceOn
29 Davis JP. Experience with hepatitis A and B vaccines. Am J Med 2005;118(suppl):S7-S15.